ANN ARBOR, Mich., September 13, 2018 – Millendo Therapeutics, Inc., a clinicalstage biopharmaceutical company focused on developing novel...

Leveraging satellite technology, Indigo releases data on an unprecedented 40,000+ acres from the 2018 commercial wheat harvest Indigo...

CAMBRIDGE, Mass. & EMERYVILLE, Calif.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) and Gritstone Oncology, Inc. today announced a...

Transaction to Advance Millendo’s Compelling Pipeline of Late-Stage Programs for Orphan Endocrine Diseases Including Prader-Willi...

SAN DIEGO, July 30, 2018 /PRNewswire/ -- Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has...

SAN DIEGO, July 27, 2018 — eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the...

Co-Founder & current Chief Operating Officer Sheila Gujrathi, M.D., appointed Chief Executive Officer Co-Founder & current Chief...

Indigo Wheat™ demonstrated average yield gains of 19% in low yielding conditions and 13% across all conditions Improving upon last year’s...

CINCINNATI & SAN DIEGO--(BUSINESS WIRE)--Aerpio Pharmaceuticals, Inc. (OTCQB:ARPO), today announced an exclusive global license agreement...